Since 2012, Prof. Ziv Gil, MD, PhD has been the chairman of the Department of Otolaryngology-Head and Neck Surgery at the Rambam Health Care Campus/Technion-Israel Institute of Technology in Haifa. During the same period, he has served as director of the Applied Cancer Research Laboratory at Rambam's Rappaport Family Institute for Research in the Medical Sciences/Technion Integrated Cancer Center. From 2008-2012, he worked at Tel Aviv Medical Center, where he served, in turn, as director of its Skull Base Surgery Service, Applied Cancer Research Laboratory, and Head and Neck Surgery Unit. Between 2006 and 2008, he was a Visiting Fellow at the University of Pittsburgh Medical Center's Center for Minimally Invasive Skull Base Surgery, and a Clinical Fellow at New York's Memorial Sloan Kettering Cancer Center. Prior to this, he was a Postdoctoral Research Fellow in the Department of Physiology and Biophysics at the University of Miami's School of Medicine. A frequent lecturerand advisor on transforming organizational cultures and change management, Prof. Gil earned his M.D. in Medicine and Ph.D. (summa cum laude) in Physiology and Neuroscience from Israel's Ben-Gurion University of the Negev. He currently serves on the board of directors of the International Federation of Head and Neck Oncologic Societies, World Federation of Skull Base Societies, Asian Society of Head & Neck Oncology, International Academy of Oral Oncology, Israel Society for Extracellular Vesicle Research, and Israeli Biorepository Network for Research. His research has been funded by numerous Israeli and international agencies, including the Israel Cancer Research Fund for which he was a Barbara S. Goodman Endowed Investigator and a supported professional in the Jacki and Bruce Barron Cancer Research Scholars’ Program. He is the recipient of the 2018 Youdim Family Prize for Excellence in Cancer Research, as well as many other awards, including those from the Israeli Parliamentand the New York Head and Neck Society.Dr. Gil has authored four books on medicine, contributed chapters to almost two dozen others, and serves on the editorial boards for multiple scientific journals and research agencies. His principal research interests focus on cancer invasion mechanisms, tumor metabolomics and microenvironments, exosomal transmission, and drug resistance.He is the leader of several international consortia in head and neck cancer, including the International Consortium for Outcome Research and the Adenoid Cystic Carcinoma International Study Group. In 2014, he established the Comprehensive Head and Neck Center on the Rambam Health Care Campus, the first of its kind in in Israel. Since then, he has founded several entrepreneurial ventures for the development of new medical devices, artificial intelligence, drug delivery systems, and medical software. To reduce costs, increase revenue, and improve the organizational performance of hospitals and other medical care facilities, Prof. Gil has also been engaged in modeling new approaches to and introducing tools for healthcare management.For eight years, he has been working with Palestinian colleagues to promote ongoing healthcare initiatives in the West Bank and Gaza. Their joint collaboration is assisting Palestinian organizations and institutions to independently deliver quality, high-level medical services, and fostering a partnership between nations.
